Delivery Order SPE2DB20D1004-SPE2DB24FG5G2

Award Date 7/25/24
Potential Completion Date 7/26/24
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product, with a ceiling value of $1,856.46 and a period of performance through January 25, 2024. The contract was awarded on a firm fixed-price basis without any set-aside requirements, indicating open competition. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product, with a ceiling value of $1,638.80 and a period of performance through February 5, 2025. The contract is a firm-fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SYNVISC-ONE SYRINGE 6ML medical products. The contract has a ceiling value of $13,456.85 and an ultimate completion date of August 29, 2024. It is a firm fixed-price contract and is not designated as a set-aside. AmerisourceBergen has been awarded numerous Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division. The contract, valued at $3,373.43, is for the supply of SYNVISC-ONE SYRINGE 6ML, a pharmaceutical product. The contract has an ultimate completion date of August 26, 2024 and is a firm-fixed-price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,657.30, is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product. The contract has an ultimate completion date of April 23, 2025 and was awarded on April 22, 2025. AmerisourceBergen Drug Corp is a for-profit organization registered in SAM.gov since 2002 and has a...
This is a $24,684.49 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product, with a period of performance through June 18, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of SYNVISC-ONE syringes. The contract, valued at $1,886.72, has a completion date of July 25, 2024. It is a firm-fixed-price contract, with no set-aside designation. Amerisourcebergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies, valued up to $999,999,999 and $750,000...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SYNVISC-ONE SYRINGE 6ML, a medical product, with a ceiling value of $2,590.08 and a period of performance through June 26, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product, with a ceiling value of $1,297.02 and a period of performance through June 10, 2025. The contract is a firm fixed-price delivery order, and there is no set-aside designation, indicating open competition. AmerisourceBergen Drug...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,459.76, is for the supply of SYNVISC-ONE SYRINGE 6ML, a specialty medical product, with a period of performance through August 7, 2024. The contract is not designated as a set-aside. In addition to this specific delivery order, AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FG5G2
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,695.26, is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product. The contract is a firm fixed-price delivery order with an ultimate completion date of July 26, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and holds significant Indefinite Delivery Contracts (IDCs) with the DLA, valued at $999,999,999, and the Department of Justice Federal Bureau of Investigation, valued at $750,000, for providing a comprehensive range of pharmaceutical products and medical supplies to support federal healthcare programs.

Generated 5/17/25, 10:09 AM